Aurobindo Pharma's Lannett Facility Completes US FDA Inspection with 4 Observations
Aurobindo Pharma’s Lannett facility in Indiana completes a US Food and Drug Administration (FDA) inspection with 4 procedural observations and will respond within the stipulated timeline.
Lannett Company | 24/08/2026 | By News Bureau
Aurobindo Pharma USA Completes Acquisition of Lannett Company
Aurobindo Pharma USA has completed the acquisition of Lannett Company after securing approval from the US Federal Trade Commission. Effective June 29, 2026, Lannett will operate as Lannett Company LLC, with the combined entity aiming to strengthen the supply of essential medicines and enhance value for patients and customers.
Lannett Company | 30/06/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy